Ex-chiral pool synthesis and pharmacological aspects of 3-pyrrolidinylisoxazoles

Employing the dopamine autoreceptor agonist (-)-3-PPP (3) as well as the cholinergic receptor ligands 4 and 5 as lead compounds the 3-pyrrolidinylisoxazoles 2a,b as well as its optical antipodes ent 2a,b were synthesized from (R)-aspartic acid (6) and (S)-aspartic acid (ent-6), respectively. Pharmacological properties of the target compounds were evaluated employing dopamine D2 receptor binding studies and functional experiments on muscarinic M2 receptors.     

THE CHARACTERISTICS OF OVARIAN SEROUS TUMORS OF BORDERLINE MALIGNANCY

During 1948-1976, 363 cases of ovarian serous tumor were encountered in the hospital. Among them, 58 cases were pathologically compatible with the criteria of this tumor of borderline ma- lignancy proposed by the WHO classification. The purp8se of this paper is threefold: 1. To study the c!inical behavior and mode of de- velopment of pathologically documented bordcr- line malignant serous ovarian tumors. 2. To compare the difference between benign, border- line malignant and malignant serous tumors. 3. To assess the value of making such a "borderline malignant" subgroup.     

The Dalkon Shield IUD

The Dalkon Shield IUD was introduced to the list of contraceptives being distributed to developing countries by IPPF (International Planned Parenthood Federation) in 1973. By 1974, doubts had arisen about the safety of the Dalkon Shield and several cases of maternal mortality and sepsis in Dalkon Shield users had been reported. In 1974, IPPF stopped supplying Dalkon Shields to its affiliates. During the 1973-74 period of distribution, IPPF had distributed approximately 300,000 of the Shields in 41 countries. Almost 1/2 that amount had already been inserted. The position of IPPF's IMAP (International Medical Advisory Panel) on any relationship existing between use of IUDs and pelvic inflammatory disease is as follows as of 1980: 1) infection with actinomycosis makes up only a small component of all the incidents of pelvic inflammatory disease connected with IUDs; 2) the occurrence of pelvic inflammatory disease is not related to the length of use of an IUD; 3) data do not now support the recommendation that inert devices free from major side effects should be removed; and 4) any woman still wearing a Dalkon Shield should have it removed.     

GREATER OMENTUM-CUTANEOUS AXIAL FLAP A METHOD TO CREATE TRANSFERABLE SKIN FLAP

In view of the fact that the blood vessels of the donor area for a free flap must be of an "axial pattern", that not all axial pattern flaps which are supplied by a direct cutaneous artery, are suitable for clincial applications, and that the availability of these flaps is greatly limited in patients with severe burns or multiple injuries, we have deviced a kind of new flap, the greater omentum-cutaneous axial flap, to replace the conventional free flap in plastic and reconstruc- tive surgery. Preliminary clinical application of this type of flap in 3 cases proved successful.     

P物质免疫反应阳性神经元胞体和终末在猴、猫前庭神经核簇中的分布

ABC法研究猴、猫前庭神经核簇(VN)内含P物质(SP)神经元胞体和终末的分布。小型SP免疫反应阳性神经元主要位于前庭神经内侧核(MVN)和前庭神经下核(IVN)的尾侧半。并散在于前庭神经节(VG)。前庭神经外侧核(LVN)内,几乎所有SP免疫反应阴性的大型神经元胞体和近端树突均为阳性终末环绕。提示SP参与前庭脊髓投射的调节。LVN不同部分的SP阳性终末有不同来源。嘴腹侧部者来自VG,尾背侧部者可能来自同侧MVN和1VN。前庭神经上核(SVN)背外侧部、MVN近头端腹外侧部等处的一些中型阴性神经元亦被阳性终末环绕。提示来自初级前庭纤维的SP参与前庭眼肌反射的调节。